Literature DB >> 17297069

Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco.

S Jane Henley1, Cari J Connell, Patricia Richter, Corinne Husten, Terry Pechacek, Eugenia E Calle, Michael J Thun.   

Abstract

BACKGROUND: Although several epidemiological studies have examined the mortality among users of spit tobacco, none have compared mortality of former cigarette smokers who substitute spit tobacco for cigarette smoking ("switchers") and smokers who quit using tobacco entirely.
METHODS: A cohort of 116,395 men were identified as switchers (n = 4443) or cigarette smokers who quit using tobacco entirely (n = 111,952) when enrolled in the ongoing US American Cancer Society Cancer Prevention Study II. From 1982 to 31 December 2002, 44 374 of these men died. The mortality hazard ratios (HR) of tobacco-related diseases, including lung cancer, coronary heart disease, stroke and chronic obstructive pulmonary disease, were estimated using Cox proportional hazards regression modelling adjusted for age and other demographic variables, as well as variables associated with smoking history, including number of years smoked, number of cigarettes smoked and age at quitting.
RESULTS: After 20 years of follow-up, switchers had a higher rate of death from any cause (HR 1.08, 95% confidence interval (CI) 1.01 to 1.15), lung cancer (HR 1.46, 95% CI 1.24 to 1.73), coronary heart disease (HR 1.13, 95% CI 1.00 to 1.29) and stroke (HR 1.24, 95% CI 1.01 to 1.53) than those who quit using tobacco entirely.
CONCLUSION: The risks of dying from major tobacco-related diseases were higher among former cigarette smokers who switched to spit tobacco after they stopped smoking than among those who quit using tobacco entirely.

Entities:  

Mesh:

Year:  2007        PMID: 17297069      PMCID: PMC2598436          DOI: 10.1136/tc.2006.018069

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  29 in total

1.  Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men.

Authors:  F Huhtasaari; V Lundberg; M Eliasson; U Janlert; K Asplund
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

2.  Smokeless tobacco and tobacco-related nitrosamines.

Authors:  Vincent Cogliano; Kurt Straif; Robert Baan; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2004-12       Impact factor: 41.316

Review 3.  Pharmacotherapy for nicotine dependence.

Authors:  Jack E Henningfield; Reginald V Fant; August R Buchhalter; Maxine L Stitzer
Journal:  CA Cancer J Clin       Date:  2005 Sep-Oct       Impact factor: 508.702

4.  Smokeless tobacco and coronary heart disease: a 12-year follow-up study.

Authors:  Sven-Erik Johansson; Kristina Sundquist; Jan Qvist; Jan Sundquist
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-08

5.  Swedish moist snuff and myocardial infarction among men.

Authors:  Maria-Pia Hergens; Anders Ahlbom; Tomas Andersson; Göran Pershagen
Journal:  Epidemiology       Date:  2005-01       Impact factor: 4.822

Review 6.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.

Authors:  S S Hecht
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

7.  Cancer incidence among a cohort of smokeless tobacco users (United States).

Authors:  Neil A Accortt; John W Waterbor; Colleen Beall; George Howard
Journal:  Cancer Causes Control       Date:  2005-11       Impact factor: 2.506

8.  Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States).

Authors:  S Jane Henley; Michael J Thun; Cari Connell; Eugenia E Calle
Journal:  Cancer Causes Control       Date:  2005-05       Impact factor: 2.506

9.  Use of smokeless tobacco among adults--United States, 1991.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-04-16       Impact factor: 17.586

10.  Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers.

Authors:  G Bolinder; L Alfredsson; A Englund; U de Faire
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

View more
  19 in total

1.  Should doctors advocate snus and other nicotine replacements? No.

Authors:  Alexander W Macara
Journal:  BMJ       Date:  2008-02-16

2.  Sweden SimSmoke: the effect of tobacco control policies on smoking and snus prevalence and attributable deaths.

Authors:  Aimee M Near; Kenneth Blackman; Laura M Currie; David T Levy
Journal:  Eur J Public Health       Date:  2013-11-27       Impact factor: 3.367

Review 3.  Systematic review of the relation between smokeless tobacco and cancer in Europe and North America.

Authors:  Peter N Lee; Jan Hamling
Journal:  BMC Med       Date:  2009-07-29       Impact factor: 8.775

Review 4.  Non-cigarette tobacco and the lung.

Authors:  Michael Schivo; Mark V Avdalovic; Susan Murin
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 5.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

Review 6.  Developing the science base for reducing tobacco harm.

Authors:  Dorothy K Hatsukami; Anne M Joseph; Mark Lesage; Joni Jensen; Sharon E Murphy; Paul R Pentel; Michael Kotlyar; Eugene Borgida; Chap Le; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

Review 7.  Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.

Authors:  Neal L Benowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

8.  The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.

Authors:  Mitchell Zeller; Dorothy Hatsukami
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

9.  Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013-2014): A Cross-sectional Analysis.

Authors:  Joanne T Chang; Juan C Vivar; Jamie Tam; Hoda T Hammad; Carol H Christensen; Dana M van Bemmel; Babita Das; Uliana Danilenko; Cindy M Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05-04       Impact factor: 4.254

Review 10.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.